Abstract
Background: Recently, increasing antibiotic resistance is causing serious publichealth concerns worldwide. This phenomenon increased patient's morbidity and mortality rate, particularly in immunocompromised individuals.
Methods: Considering that antimicrobial resistance can vary according to geographical location, we investigated the status of antibiotic resistance in Ilam province from 2008 to 2013.
Results: The results of our study showed that antibiotic resistance rates to aztreonam, cefotaxime, ceftazidime and ceftriaxone were 38%, 39%, 43% and 48% respectively.
Conclusion: Antibiotic resistance had increased (except for aztreonam) during the period from 2008 to 2013.
Keywords: Antibiotic resistances, antimicrobial resistance, meta-analysis, monobactam, Ilam, ceftazidime.
Graphical Abstract
Recent Patents on Anti-Infective Drug Discovery
Title:3rd Generation of Cephalosporins and Monobactam Resistant Among Pathogenic Bacteria Collected from Ilam Hospitals During 2008 to 2015: A Systematic Review and Meta-Analysis
Volume: 12 Issue: 1
Author(s): Saeed Hemati, Sobhan Ghafourian, Nourkhoda Sadeghfard, Zahra Mahdavi, Abbas Maleki, Fatemeh Sayehmiri, Kouroush Sayehmiri, Lidija Bogdanovic and Morovat Taherikalani*
Affiliation:
- Razi Herbal Medicines Research Center & Department of Microbiology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad,Iran
Keywords: Antibiotic resistances, antimicrobial resistance, meta-analysis, monobactam, Ilam, ceftazidime.
Abstract: Background: Recently, increasing antibiotic resistance is causing serious publichealth concerns worldwide. This phenomenon increased patient's morbidity and mortality rate, particularly in immunocompromised individuals.
Methods: Considering that antimicrobial resistance can vary according to geographical location, we investigated the status of antibiotic resistance in Ilam province from 2008 to 2013.
Results: The results of our study showed that antibiotic resistance rates to aztreonam, cefotaxime, ceftazidime and ceftriaxone were 38%, 39%, 43% and 48% respectively.
Conclusion: Antibiotic resistance had increased (except for aztreonam) during the period from 2008 to 2013.
Export Options
About this article
Cite this article as:
Hemati Saeed, Ghafourian Sobhan, Sadeghfard Nourkhoda, Mahdavi Zahra, Maleki Abbas, Sayehmiri Fatemeh, Sayehmiri Kouroush, Bogdanovic Lidija and Taherikalani Morovat*, 3rd Generation of Cephalosporins and Monobactam Resistant Among Pathogenic Bacteria Collected from Ilam Hospitals During 2008 to 2015: A Systematic Review and Meta-Analysis, Recent Patents on Anti-Infective Drug Discovery 2017; 12 (1) . https://dx.doi.org/10.2174/1574891X12666170130101006
DOI https://dx.doi.org/10.2174/1574891X12666170130101006 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
CA125: An Increasingly Promising Biomarker of Heart Failure
Current Pharmaceutical Design Antibacterial Combination of Oleoresin from Copaifera multijuga Hayne and Biogenic Silver Nanoparticles Towards Streptococcus agalactiae
Current Pharmaceutical Biotechnology Comparative Time-Kill Study of Doxycycline, Tigecycline, Cefazolin and Vancomycin Against Several Clones of Staphylococcus aureus
Current Clinical Pharmacology Role of Bone Marrow in the Pathogenesis of Rheumatoid Arthritis
Current Rheumatology Reviews Arthritis and Periodontitis: An Association Debated for Over Two Centuries
Current Rheumatology Reviews Gut Microbiota of Obese, Type 2 Diabetic Individuals is Enriched in Faecalibacterium prausnitzii, Akkermansia muciniphila and Peptostreptococcus anaerobius after Weight Loss
Endocrine, Metabolic & Immune Disorders - Drug Targets Association of Pharmacokinetic and Pharmacodynamic Aspects of Linezolid with Infection Outcome
Current Drug Metabolism Bacteriophage and Peptidoglycan Degrading Enzymes with Antimicrobial Applications
Recent Patents on Biotechnology Novel Approaches to Control Biofilm Infections
Current Medicinal Chemistry Postoperative Complications in Hemorrhoidal Disease and Special Conditions
Reviews on Recent Clinical Trials Systematic Reviews of Animal Experiments Demonstrate Poor Contributions Toward Human Healthcare
Reviews on Recent Clinical Trials Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer
Current Pharmaceutical Design Novel Perspective for Antithrombotic Therapy in TAVI
Current Pharmaceutical Design Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study
Current HIV Research Current Status of Carbapenem Antibiotics
Current Topics in Medicinal Chemistry A Review of the Carbapenems in Clinical Use and Clinical Trials
Recent Patents on Anti-Infective Drug Discovery Chemistry and Pharmacology of Neglected Helminthic Diseases
Current Medicinal Chemistry The Co-Metabolism within the Gut-Brain Metabolic Interaction: Potential Targets for Drug Treatment and Design
CNS & Neurological Disorders - Drug Targets A Review of Macrolide Treatment of Atherosclerosis and Abdominal Aortic Aneurysms
Current Drug Targets - Infectious Disorders Bergenin - A Biologically Active Scaffold: Nanotechnological Perspectives
Current Topics in Medicinal Chemistry